- Narducci DM
- Diamond AB
- Bernhardt DT
- Roberts wo
there has been evidence of reluctance to vaccinate in some groups.
- Ainslie D
- Ogwuru C
- Sinclair R
For athletes, a major concern is the potential effect of side effects associated with the vaccine on sport participation;
- JH shell
- Deputy Schwellnus
- BD Pyne
- Shah A
even brief interruptions in training can affect athletic performance.
- Drew MK
- Raysmith BP
- Charlton PC
Complete data were available for 127 athletes (57 [45%] woman, 70 years old [55%] Male; average age 27.5 years [SD 4·9]) who received two doses of the Pfizer-BioNTech tozinameran vaccine (BNT162b2), administered between May 12 and September 2, 2021, according to licensed recommendations, from 435 athletes regularly using a COVID-19 monitoring app. Of these participants, 97 (76%) were Olympic athletes and 30 (24%) were Paralympic athletes, 67 having subsequently competed in the Tokyo Olympics and 22 in the Tokyo Paralympic Games.
- Menni C
- Klaser K
- one may
- et al.
Our results indicate that continuing to exercise after vaccination against SARS CoV-2 is also appropriate. Indeed, exercising during the peri-vaccination period could improve the immune response,
- Baker FL
- Smith KA
- Zúñiga TM
- et al.
although further studies in this area are needed. Protecting elite athletes from infection with SARS-CoV-2 is important, 2021 report says about one in four has not fully returned to sport within a month of onset of infection .
- JH shell
- Wootten M
- Moghal M
- et al.
Potential weaknesses of our study include the fact that the cohort was small and therefore insufficiently fed to detect infrequent adverse events. Our dataset also only provides information on tozinameran; the UK vaccination strategy has promoted the use of this type of vaccine in young people, so more work is needed to assess the impact of other SARS-CoV-2 vaccines in this population. Our methodological approach could also be used to assess the tolerability and impact of non-SARS CoV-2 vaccines.
In conclusion, in elite athletes, vaccination against SARS-CoV-2 with the Pfizer-BioNTech tozinameran vaccine appears to be well tolerated and associated with few significant side effects. When side effects did occur, they were short lived and did not affect sports participation. This analysis should help inform the discussion regarding the risks and benefits of SARS-CoV-2 vaccination in the context of sport.
We do not declare any competing interests. We thank the athletes for their contribution to the data collection and to the EIS Athlete Health and Performance Data teams for the development of the tracking application.
COVID vaccination in athletes and update to interim guidelines on pre-participation physical examination during the SARS-Cov-2 pandemic.
Clin J Sport Med. 2021; ()
Coronavirus and vaccine hesitation, Great Britain: August 9, 2021.
Some British Olympic athletes are refusing the COVID vaccine for fear of side effects.
COVID-19 vaccination in athletes: ready, ready, go….
Lancet Respir Med. 2021; 9: 455-456
Injuries Compromise Athletes’ Chances of Success: A Systematic Review.
Br J Sports Med. 2017; 51: 1209-1214
Vaccine side effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study.
Lancet Infect Dis. 2021; 21: 939-949
Vaccination in elite athletes.
Med. Athletic. 2014 ; 44: 1361-1376
Acute exercise increases immune responses to SARS CoV-2 in a previously infected man.
Brain Behavior Health Immune. 2021; 18100343
Clinical models, recovery time and prolonged impact of COVID-19 disease in international athletes: the UK experience.
Br J Sports Med. 2021; ()
Posted: December 10, 2021
© 2021 Elsevier Ltd. All rights reserved.
Access this article on ScienceDirect